Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China flag China · Delayed Price · Currency is CNY
10.15
+0.13 (1.30%)
At close: Mar 30, 2026

SHE:002873 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
9.1152.3280.87111.52100.61
Depreciation & Amortization
39.4336.1223.3425.4522.81
Other Amortization
5.052.871.471.282.69
Loss (Gain) From Sale of Assets
0.78-18.9-0.020.1
Asset Writedown & Restructuring Costs
3.780.710.070.120.37
Loss (Gain) From Sale of Investments
-0.01-0.020.720.4-
Provision & Write-off of Bad Debts
-2.61-0.270.521.73
Other Operating Activities
16.4423.3316.1115.2317.52
Change in Accounts Receivable
49.95-38.037-20.18-8.45
Change in Inventory
-30.2335.8-1.2-66.75-40.35
Change in Accounts Payable
-11.11-10-52.081.7925.94
Operating Cash Flow
83.7388.1377.7875.82124.3
Operating Cash Flow Growth
-4.99%13.30%2.59%-39.00%-29.28%
Capital Expenditures
-51.59-61.45-101.7-129.2-105.69
Sale of Property, Plant & Equipment
2.1415.0850.030.08
Cash Acquisitions
-2.99----
Investment in Securities
-400050-112
Other Investing Activities
0.01----
Investing Cash Flow
-92.43-46.37-96.7-79.17-217.61
Long-Term Debt Issued
532.75680506347273
Total Debt Issued
532.75680506347273
Long-Term Debt Repaid
-421.63-577.29-404-278-418.63
Total Debt Repaid
-421.63-577.29-404-278-418.63
Net Debt Issued (Repaid)
111.12102.7110269-145.63
Issuance of Common Stock
----27.81
Repurchase of Common Stock
--129.48-2.99-3.1-15.02
Common Dividends Paid
-41.42-35.06-42.53-34.35-30.33
Other Financing Activities
-5.44----1.12
Financing Cash Flow
64.25-61.8356.4831.54-164.3
Foreign Exchange Rate Adjustments
--0--
Net Cash Flow
55.56-20.0737.5728.19-257.61
Free Cash Flow
32.1426.68-23.92-53.3818.61
Free Cash Flow Growth
20.48%----82.71%
Free Cash Flow Margin
4.29%3.11%-2.51%-4.91%1.92%
Free Cash Flow Per Share
0.140.12-0.10-0.220.08
Cash Income Tax Paid
86.3379.8697.63117.84112
Levered Free Cash Flow
21.2-6.5-31.37-97.92-17.28
Unlevered Free Cash Flow
21.24.48-23.99-91.24-6.9
Change in Working Capital
9.15-10.9-44.54-78.71-21.52
Source: S&P Global Market Intelligence. Standard template. Financial Sources.